Washington, D.C. government relations director and District Policy Group Senior Vice President Julie Scott Allen spoke at the opening plenary session on a panel titled, “Reimbursement and Policy Outlook for Labs and Pathologists,” at the 32 Annual G2-Bloomberg BNA Lab Institute Conference on Thursday, October 16.
During her presentation, Julie represented the American Association of Bioanalysts and National Independent Laboratory Association, clients of the firm. She provided the perspective of community and multi-regional independent laboratories who oppose a new law that requires mandatory reporting to the federal government of private payer rates for laboratory services and revises Medicare payments to match those rates. Her presentation ran counterpoint to the perspective offered by the national laboratories, represented on the panel by the American Clinical Laboratory Association. Also represented on the panel was the College of American Pathologists. The panel addressed key laboratory payment changes and their implications under Medicare Part B as included in the Protecting Access to Medicare Act of 2014 as well as other major policy issues facing the laboratory market, including the Food and Drug Administration’s (FDA) intent to regulate laboratory developed tests.